Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection
Rationale: Nasopharyngeal administration of live virulence-attenuated <i<Streptococcus pneumoniae</i< strains is a potential novel preventative strategy. One target for creating reduced virulence <i<S. pneumoniae</i< strains is the capsule, but loss of the capsule reduces the...
Ausführliche Beschreibung
Autor*in: |
Elisa Ramos-Sevillano [verfasserIn] Giuseppe Ercoli [verfasserIn] José Afonso Guerra-Assunção [verfasserIn] Philip Felgner [verfasserIn] Rafael Ramiro de Assis [verfasserIn] Rie Nakajima [verfasserIn] David Goldblatt [verfasserIn] Kevin Kweku Adjei Tetteh [verfasserIn] Robert Simon Heyderman [verfasserIn] Stephen Brian Gordon [verfasserIn] Daniela Mulari Ferreria [verfasserIn] Jeremy Stuart Brown [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2021 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Vaccines - MDPI AG, 2013, 9(2021), 3, p 261 |
---|---|
Übergeordnetes Werk: |
volume:9 ; year:2021 ; number:3, p 261 |
Links: |
---|
DOI / URN: |
10.3390/vaccines9030261 |
---|
Katalog-ID: |
DOAJ079235166 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ079235166 | ||
003 | DE-627 | ||
005 | 20240412190923.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230307s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/vaccines9030261 |2 doi | |
035 | |a (DE-627)DOAJ079235166 | ||
035 | |a (DE-599)DOAJ49a7fad3616a46729a4e6aada6193bc7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a Elisa Ramos-Sevillano |e verfasserin |4 aut | |
245 | 1 | 0 | |a Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Rationale: Nasopharyngeal administration of live virulence-attenuated <i<Streptococcus pneumoniae</i< strains is a potential novel preventative strategy. One target for creating reduced virulence <i<S. pneumoniae</i< strains is the capsule, but loss of the capsule reduces the duration of <i<S. pneumoniae</i< colonisation in mice which could impair protective efficacy against subsequent infection. Objectives: To assess protective efficacy of nasopharyngeal administration of unencapsulated <i<S. pneumoniae</i< strains in murine infection models. Methods: Strains containing <i<cps</i< locus deletions combined with the <i<S. pneumoniae</i< virulence factors <i<psaA</i< (reduces colonisation) or <i<proABC</i< (no effect on colonisation) were constructed and their virulence phenotypes and ability to prevent recolonisation or invasive infection assessed using mouse infection models. Serological responses to colonisation were compared between strains using ELISAs, immunoblots and 254 <i<S. pneumoniae</i< protein antigen array. Measurements and Main Results: The <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains were strongly attenuated in virulence in both invasive infection models and had a reduced ability to colonise the nasopharynx. ELISAs, immunoblots and protein arrays showed colonisation with either strain stimulated weaker serological responses than the wild type strain. Mice previously colonised with these strains were protected against septicaemic pneumonia but, unlike mice colonised with the wild type strain, not against <i<S. pneumoniae</i< recolonisation. Conclusions: Colonisation with the <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains prevented subsequent septicaemia, but in contrast, to published data for encapsulated double mutant strains they did not prevent recolonisation with <i<S. pneumoniae</i<. These data suggest targeting the <i<cps</i< locus is a less effective option for creating live attenuated strains that prevent <i<S. pneumoniae</i< infections. | ||
650 | 4 | |a <i<Streptococcus pneumoniae</i< | |
650 | 4 | |a capsule | |
650 | 4 | |a vaccine | |
650 | 4 | |a <i<psaA</i< | |
650 | 4 | |a <i<proABC</i< | |
650 | 4 | |a colonisation | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
700 | 0 | |a Giuseppe Ercoli |e verfasserin |4 aut | |
700 | 0 | |a José Afonso Guerra-Assunção |e verfasserin |4 aut | |
700 | 0 | |a Philip Felgner |e verfasserin |4 aut | |
700 | 0 | |a Rafael Ramiro de Assis |e verfasserin |4 aut | |
700 | 0 | |a Rie Nakajima |e verfasserin |4 aut | |
700 | 0 | |a David Goldblatt |e verfasserin |4 aut | |
700 | 0 | |a Kevin Kweku Adjei Tetteh |e verfasserin |4 aut | |
700 | 0 | |a Robert Simon Heyderman |e verfasserin |4 aut | |
700 | 0 | |a Stephen Brian Gordon |e verfasserin |4 aut | |
700 | 0 | |a Daniela Mulari Ferreria |e verfasserin |4 aut | |
700 | 0 | |a Jeremy Stuart Brown |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Vaccines |d MDPI AG, 2013 |g 9(2021), 3, p 261 |w (DE-627)736559205 |w (DE-600)2703319-3 |x 2076393X |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2021 |g number:3, p 261 |
856 | 4 | 0 | |u https://doi.org/10.3390/vaccines9030261 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/49a7fad3616a46729a4e6aada6193bc7 |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/2076-393X/9/3/261 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2076-393X |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 9 |j 2021 |e 3, p 261 |
author_variant |
e r s ers g e ge j a g a jaga p f pf r r d a rrda r n rn d g dg k k a t kkat r s h rsh s b g sbg d m f dmf j s b jsb |
---|---|
matchkey_str |
article:2076393X:2021----::rtciefetfaaclnstowtippainippobisrpoocsnuoiesrisgi |
hierarchy_sort_str |
2021 |
publishDate |
2021 |
allfields |
10.3390/vaccines9030261 doi (DE-627)DOAJ079235166 (DE-599)DOAJ49a7fad3616a46729a4e6aada6193bc7 DE-627 ger DE-627 rakwb eng Elisa Ramos-Sevillano verfasserin aut Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Rationale: Nasopharyngeal administration of live virulence-attenuated <i<Streptococcus pneumoniae</i< strains is a potential novel preventative strategy. One target for creating reduced virulence <i<S. pneumoniae</i< strains is the capsule, but loss of the capsule reduces the duration of <i<S. pneumoniae</i< colonisation in mice which could impair protective efficacy against subsequent infection. Objectives: To assess protective efficacy of nasopharyngeal administration of unencapsulated <i<S. pneumoniae</i< strains in murine infection models. Methods: Strains containing <i<cps</i< locus deletions combined with the <i<S. pneumoniae</i< virulence factors <i<psaA</i< (reduces colonisation) or <i<proABC</i< (no effect on colonisation) were constructed and their virulence phenotypes and ability to prevent recolonisation or invasive infection assessed using mouse infection models. Serological responses to colonisation were compared between strains using ELISAs, immunoblots and 254 <i<S. pneumoniae</i< protein antigen array. Measurements and Main Results: The <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains were strongly attenuated in virulence in both invasive infection models and had a reduced ability to colonise the nasopharynx. ELISAs, immunoblots and protein arrays showed colonisation with either strain stimulated weaker serological responses than the wild type strain. Mice previously colonised with these strains were protected against septicaemic pneumonia but, unlike mice colonised with the wild type strain, not against <i<S. pneumoniae</i< recolonisation. Conclusions: Colonisation with the <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains prevented subsequent septicaemia, but in contrast, to published data for encapsulated double mutant strains they did not prevent recolonisation with <i<S. pneumoniae</i<. These data suggest targeting the <i<cps</i< locus is a less effective option for creating live attenuated strains that prevent <i<S. pneumoniae</i< infections. <i<Streptococcus pneumoniae</i< capsule vaccine <i<psaA</i< <i<proABC</i< colonisation Medicine R Giuseppe Ercoli verfasserin aut José Afonso Guerra-Assunção verfasserin aut Philip Felgner verfasserin aut Rafael Ramiro de Assis verfasserin aut Rie Nakajima verfasserin aut David Goldblatt verfasserin aut Kevin Kweku Adjei Tetteh verfasserin aut Robert Simon Heyderman verfasserin aut Stephen Brian Gordon verfasserin aut Daniela Mulari Ferreria verfasserin aut Jeremy Stuart Brown verfasserin aut In Vaccines MDPI AG, 2013 9(2021), 3, p 261 (DE-627)736559205 (DE-600)2703319-3 2076393X nnns volume:9 year:2021 number:3, p 261 https://doi.org/10.3390/vaccines9030261 kostenfrei https://doaj.org/article/49a7fad3616a46729a4e6aada6193bc7 kostenfrei https://www.mdpi.com/2076-393X/9/3/261 kostenfrei https://doaj.org/toc/2076-393X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2021 3, p 261 |
spelling |
10.3390/vaccines9030261 doi (DE-627)DOAJ079235166 (DE-599)DOAJ49a7fad3616a46729a4e6aada6193bc7 DE-627 ger DE-627 rakwb eng Elisa Ramos-Sevillano verfasserin aut Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Rationale: Nasopharyngeal administration of live virulence-attenuated <i<Streptococcus pneumoniae</i< strains is a potential novel preventative strategy. One target for creating reduced virulence <i<S. pneumoniae</i< strains is the capsule, but loss of the capsule reduces the duration of <i<S. pneumoniae</i< colonisation in mice which could impair protective efficacy against subsequent infection. Objectives: To assess protective efficacy of nasopharyngeal administration of unencapsulated <i<S. pneumoniae</i< strains in murine infection models. Methods: Strains containing <i<cps</i< locus deletions combined with the <i<S. pneumoniae</i< virulence factors <i<psaA</i< (reduces colonisation) or <i<proABC</i< (no effect on colonisation) were constructed and their virulence phenotypes and ability to prevent recolonisation or invasive infection assessed using mouse infection models. Serological responses to colonisation were compared between strains using ELISAs, immunoblots and 254 <i<S. pneumoniae</i< protein antigen array. Measurements and Main Results: The <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains were strongly attenuated in virulence in both invasive infection models and had a reduced ability to colonise the nasopharynx. ELISAs, immunoblots and protein arrays showed colonisation with either strain stimulated weaker serological responses than the wild type strain. Mice previously colonised with these strains were protected against septicaemic pneumonia but, unlike mice colonised with the wild type strain, not against <i<S. pneumoniae</i< recolonisation. Conclusions: Colonisation with the <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains prevented subsequent septicaemia, but in contrast, to published data for encapsulated double mutant strains they did not prevent recolonisation with <i<S. pneumoniae</i<. These data suggest targeting the <i<cps</i< locus is a less effective option for creating live attenuated strains that prevent <i<S. pneumoniae</i< infections. <i<Streptococcus pneumoniae</i< capsule vaccine <i<psaA</i< <i<proABC</i< colonisation Medicine R Giuseppe Ercoli verfasserin aut José Afonso Guerra-Assunção verfasserin aut Philip Felgner verfasserin aut Rafael Ramiro de Assis verfasserin aut Rie Nakajima verfasserin aut David Goldblatt verfasserin aut Kevin Kweku Adjei Tetteh verfasserin aut Robert Simon Heyderman verfasserin aut Stephen Brian Gordon verfasserin aut Daniela Mulari Ferreria verfasserin aut Jeremy Stuart Brown verfasserin aut In Vaccines MDPI AG, 2013 9(2021), 3, p 261 (DE-627)736559205 (DE-600)2703319-3 2076393X nnns volume:9 year:2021 number:3, p 261 https://doi.org/10.3390/vaccines9030261 kostenfrei https://doaj.org/article/49a7fad3616a46729a4e6aada6193bc7 kostenfrei https://www.mdpi.com/2076-393X/9/3/261 kostenfrei https://doaj.org/toc/2076-393X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2021 3, p 261 |
allfields_unstemmed |
10.3390/vaccines9030261 doi (DE-627)DOAJ079235166 (DE-599)DOAJ49a7fad3616a46729a4e6aada6193bc7 DE-627 ger DE-627 rakwb eng Elisa Ramos-Sevillano verfasserin aut Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Rationale: Nasopharyngeal administration of live virulence-attenuated <i<Streptococcus pneumoniae</i< strains is a potential novel preventative strategy. One target for creating reduced virulence <i<S. pneumoniae</i< strains is the capsule, but loss of the capsule reduces the duration of <i<S. pneumoniae</i< colonisation in mice which could impair protective efficacy against subsequent infection. Objectives: To assess protective efficacy of nasopharyngeal administration of unencapsulated <i<S. pneumoniae</i< strains in murine infection models. Methods: Strains containing <i<cps</i< locus deletions combined with the <i<S. pneumoniae</i< virulence factors <i<psaA</i< (reduces colonisation) or <i<proABC</i< (no effect on colonisation) were constructed and their virulence phenotypes and ability to prevent recolonisation or invasive infection assessed using mouse infection models. Serological responses to colonisation were compared between strains using ELISAs, immunoblots and 254 <i<S. pneumoniae</i< protein antigen array. Measurements and Main Results: The <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains were strongly attenuated in virulence in both invasive infection models and had a reduced ability to colonise the nasopharynx. ELISAs, immunoblots and protein arrays showed colonisation with either strain stimulated weaker serological responses than the wild type strain. Mice previously colonised with these strains were protected against septicaemic pneumonia but, unlike mice colonised with the wild type strain, not against <i<S. pneumoniae</i< recolonisation. Conclusions: Colonisation with the <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains prevented subsequent septicaemia, but in contrast, to published data for encapsulated double mutant strains they did not prevent recolonisation with <i<S. pneumoniae</i<. These data suggest targeting the <i<cps</i< locus is a less effective option for creating live attenuated strains that prevent <i<S. pneumoniae</i< infections. <i<Streptococcus pneumoniae</i< capsule vaccine <i<psaA</i< <i<proABC</i< colonisation Medicine R Giuseppe Ercoli verfasserin aut José Afonso Guerra-Assunção verfasserin aut Philip Felgner verfasserin aut Rafael Ramiro de Assis verfasserin aut Rie Nakajima verfasserin aut David Goldblatt verfasserin aut Kevin Kweku Adjei Tetteh verfasserin aut Robert Simon Heyderman verfasserin aut Stephen Brian Gordon verfasserin aut Daniela Mulari Ferreria verfasserin aut Jeremy Stuart Brown verfasserin aut In Vaccines MDPI AG, 2013 9(2021), 3, p 261 (DE-627)736559205 (DE-600)2703319-3 2076393X nnns volume:9 year:2021 number:3, p 261 https://doi.org/10.3390/vaccines9030261 kostenfrei https://doaj.org/article/49a7fad3616a46729a4e6aada6193bc7 kostenfrei https://www.mdpi.com/2076-393X/9/3/261 kostenfrei https://doaj.org/toc/2076-393X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2021 3, p 261 |
allfieldsGer |
10.3390/vaccines9030261 doi (DE-627)DOAJ079235166 (DE-599)DOAJ49a7fad3616a46729a4e6aada6193bc7 DE-627 ger DE-627 rakwb eng Elisa Ramos-Sevillano verfasserin aut Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Rationale: Nasopharyngeal administration of live virulence-attenuated <i<Streptococcus pneumoniae</i< strains is a potential novel preventative strategy. One target for creating reduced virulence <i<S. pneumoniae</i< strains is the capsule, but loss of the capsule reduces the duration of <i<S. pneumoniae</i< colonisation in mice which could impair protective efficacy against subsequent infection. Objectives: To assess protective efficacy of nasopharyngeal administration of unencapsulated <i<S. pneumoniae</i< strains in murine infection models. Methods: Strains containing <i<cps</i< locus deletions combined with the <i<S. pneumoniae</i< virulence factors <i<psaA</i< (reduces colonisation) or <i<proABC</i< (no effect on colonisation) were constructed and their virulence phenotypes and ability to prevent recolonisation or invasive infection assessed using mouse infection models. Serological responses to colonisation were compared between strains using ELISAs, immunoblots and 254 <i<S. pneumoniae</i< protein antigen array. Measurements and Main Results: The <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains were strongly attenuated in virulence in both invasive infection models and had a reduced ability to colonise the nasopharynx. ELISAs, immunoblots and protein arrays showed colonisation with either strain stimulated weaker serological responses than the wild type strain. Mice previously colonised with these strains were protected against septicaemic pneumonia but, unlike mice colonised with the wild type strain, not against <i<S. pneumoniae</i< recolonisation. Conclusions: Colonisation with the <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains prevented subsequent septicaemia, but in contrast, to published data for encapsulated double mutant strains they did not prevent recolonisation with <i<S. pneumoniae</i<. These data suggest targeting the <i<cps</i< locus is a less effective option for creating live attenuated strains that prevent <i<S. pneumoniae</i< infections. <i<Streptococcus pneumoniae</i< capsule vaccine <i<psaA</i< <i<proABC</i< colonisation Medicine R Giuseppe Ercoli verfasserin aut José Afonso Guerra-Assunção verfasserin aut Philip Felgner verfasserin aut Rafael Ramiro de Assis verfasserin aut Rie Nakajima verfasserin aut David Goldblatt verfasserin aut Kevin Kweku Adjei Tetteh verfasserin aut Robert Simon Heyderman verfasserin aut Stephen Brian Gordon verfasserin aut Daniela Mulari Ferreria verfasserin aut Jeremy Stuart Brown verfasserin aut In Vaccines MDPI AG, 2013 9(2021), 3, p 261 (DE-627)736559205 (DE-600)2703319-3 2076393X nnns volume:9 year:2021 number:3, p 261 https://doi.org/10.3390/vaccines9030261 kostenfrei https://doaj.org/article/49a7fad3616a46729a4e6aada6193bc7 kostenfrei https://www.mdpi.com/2076-393X/9/3/261 kostenfrei https://doaj.org/toc/2076-393X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2021 3, p 261 |
allfieldsSound |
10.3390/vaccines9030261 doi (DE-627)DOAJ079235166 (DE-599)DOAJ49a7fad3616a46729a4e6aada6193bc7 DE-627 ger DE-627 rakwb eng Elisa Ramos-Sevillano verfasserin aut Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Rationale: Nasopharyngeal administration of live virulence-attenuated <i<Streptococcus pneumoniae</i< strains is a potential novel preventative strategy. One target for creating reduced virulence <i<S. pneumoniae</i< strains is the capsule, but loss of the capsule reduces the duration of <i<S. pneumoniae</i< colonisation in mice which could impair protective efficacy against subsequent infection. Objectives: To assess protective efficacy of nasopharyngeal administration of unencapsulated <i<S. pneumoniae</i< strains in murine infection models. Methods: Strains containing <i<cps</i< locus deletions combined with the <i<S. pneumoniae</i< virulence factors <i<psaA</i< (reduces colonisation) or <i<proABC</i< (no effect on colonisation) were constructed and their virulence phenotypes and ability to prevent recolonisation or invasive infection assessed using mouse infection models. Serological responses to colonisation were compared between strains using ELISAs, immunoblots and 254 <i<S. pneumoniae</i< protein antigen array. Measurements and Main Results: The <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains were strongly attenuated in virulence in both invasive infection models and had a reduced ability to colonise the nasopharynx. ELISAs, immunoblots and protein arrays showed colonisation with either strain stimulated weaker serological responses than the wild type strain. Mice previously colonised with these strains were protected against septicaemic pneumonia but, unlike mice colonised with the wild type strain, not against <i<S. pneumoniae</i< recolonisation. Conclusions: Colonisation with the <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains prevented subsequent septicaemia, but in contrast, to published data for encapsulated double mutant strains they did not prevent recolonisation with <i<S. pneumoniae</i<. These data suggest targeting the <i<cps</i< locus is a less effective option for creating live attenuated strains that prevent <i<S. pneumoniae</i< infections. <i<Streptococcus pneumoniae</i< capsule vaccine <i<psaA</i< <i<proABC</i< colonisation Medicine R Giuseppe Ercoli verfasserin aut José Afonso Guerra-Assunção verfasserin aut Philip Felgner verfasserin aut Rafael Ramiro de Assis verfasserin aut Rie Nakajima verfasserin aut David Goldblatt verfasserin aut Kevin Kweku Adjei Tetteh verfasserin aut Robert Simon Heyderman verfasserin aut Stephen Brian Gordon verfasserin aut Daniela Mulari Ferreria verfasserin aut Jeremy Stuart Brown verfasserin aut In Vaccines MDPI AG, 2013 9(2021), 3, p 261 (DE-627)736559205 (DE-600)2703319-3 2076393X nnns volume:9 year:2021 number:3, p 261 https://doi.org/10.3390/vaccines9030261 kostenfrei https://doaj.org/article/49a7fad3616a46729a4e6aada6193bc7 kostenfrei https://www.mdpi.com/2076-393X/9/3/261 kostenfrei https://doaj.org/toc/2076-393X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2021 3, p 261 |
language |
English |
source |
In Vaccines 9(2021), 3, p 261 volume:9 year:2021 number:3, p 261 |
sourceStr |
In Vaccines 9(2021), 3, p 261 volume:9 year:2021 number:3, p 261 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
<i<Streptococcus pneumoniae</i< capsule vaccine <i<psaA</i< <i<proABC</i< colonisation Medicine R |
isfreeaccess_bool |
true |
container_title |
Vaccines |
authorswithroles_txt_mv |
Elisa Ramos-Sevillano @@aut@@ Giuseppe Ercoli @@aut@@ José Afonso Guerra-Assunção @@aut@@ Philip Felgner @@aut@@ Rafael Ramiro de Assis @@aut@@ Rie Nakajima @@aut@@ David Goldblatt @@aut@@ Kevin Kweku Adjei Tetteh @@aut@@ Robert Simon Heyderman @@aut@@ Stephen Brian Gordon @@aut@@ Daniela Mulari Ferreria @@aut@@ Jeremy Stuart Brown @@aut@@ |
publishDateDaySort_date |
2021-01-01T00:00:00Z |
hierarchy_top_id |
736559205 |
id |
DOAJ079235166 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ079235166</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240412190923.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230307s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/vaccines9030261</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ079235166</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ49a7fad3616a46729a4e6aada6193bc7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Elisa Ramos-Sevillano</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Rationale: Nasopharyngeal administration of live virulence-attenuated <i<Streptococcus pneumoniae</i< strains is a potential novel preventative strategy. One target for creating reduced virulence <i<S. pneumoniae</i< strains is the capsule, but loss of the capsule reduces the duration of <i<S. pneumoniae</i< colonisation in mice which could impair protective efficacy against subsequent infection. Objectives: To assess protective efficacy of nasopharyngeal administration of unencapsulated <i<S. pneumoniae</i< strains in murine infection models. Methods: Strains containing <i<cps</i< locus deletions combined with the <i<S. pneumoniae</i< virulence factors <i<psaA</i< (reduces colonisation) or <i<proABC</i< (no effect on colonisation) were constructed and their virulence phenotypes and ability to prevent recolonisation or invasive infection assessed using mouse infection models. Serological responses to colonisation were compared between strains using ELISAs, immunoblots and 254 <i<S. pneumoniae</i< protein antigen array. Measurements and Main Results: The <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains were strongly attenuated in virulence in both invasive infection models and had a reduced ability to colonise the nasopharynx. ELISAs, immunoblots and protein arrays showed colonisation with either strain stimulated weaker serological responses than the wild type strain. Mice previously colonised with these strains were protected against septicaemic pneumonia but, unlike mice colonised with the wild type strain, not against <i<S. pneumoniae</i< recolonisation. Conclusions: Colonisation with the <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains prevented subsequent septicaemia, but in contrast, to published data for encapsulated double mutant strains they did not prevent recolonisation with <i<S. pneumoniae</i<. These data suggest targeting the <i<cps</i< locus is a less effective option for creating live attenuated strains that prevent <i<S. pneumoniae</i< infections.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Streptococcus pneumoniae</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">capsule</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vaccine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<psaA</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<proABC</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">colonisation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Giuseppe Ercoli</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">José Afonso Guerra-Assunção</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Philip Felgner</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rafael Ramiro de Assis</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rie Nakajima</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">David Goldblatt</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kevin Kweku Adjei Tetteh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Robert Simon Heyderman</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Stephen Brian Gordon</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Daniela Mulari Ferreria</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jeremy Stuart Brown</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Vaccines</subfield><subfield code="d">MDPI AG, 2013</subfield><subfield code="g">9(2021), 3, p 261</subfield><subfield code="w">(DE-627)736559205</subfield><subfield code="w">(DE-600)2703319-3</subfield><subfield code="x">2076393X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:3, p 261</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/vaccines9030261</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/49a7fad3616a46729a4e6aada6193bc7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2076-393X/9/3/261</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2076-393X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">2021</subfield><subfield code="e">3, p 261</subfield></datafield></record></collection>
|
author |
Elisa Ramos-Sevillano |
spellingShingle |
Elisa Ramos-Sevillano misc <i<Streptococcus pneumoniae</i< misc capsule misc vaccine misc <i<psaA</i< misc <i<proABC</i< misc colonisation misc Medicine misc R Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection |
authorStr |
Elisa Ramos-Sevillano |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)736559205 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
2076393X |
topic_title |
Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection <i<Streptococcus pneumoniae</i< capsule vaccine <i<psaA</i< <i<proABC</i< colonisation |
topic |
misc <i<Streptococcus pneumoniae</i< misc capsule misc vaccine misc <i<psaA</i< misc <i<proABC</i< misc colonisation misc Medicine misc R |
topic_unstemmed |
misc <i<Streptococcus pneumoniae</i< misc capsule misc vaccine misc <i<psaA</i< misc <i<proABC</i< misc colonisation misc Medicine misc R |
topic_browse |
misc <i<Streptococcus pneumoniae</i< misc capsule misc vaccine misc <i<psaA</i< misc <i<proABC</i< misc colonisation misc Medicine misc R |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Vaccines |
hierarchy_parent_id |
736559205 |
hierarchy_top_title |
Vaccines |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)736559205 (DE-600)2703319-3 |
title |
Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection |
ctrlnum |
(DE-627)DOAJ079235166 (DE-599)DOAJ49a7fad3616a46729a4e6aada6193bc7 |
title_full |
Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection |
author_sort |
Elisa Ramos-Sevillano |
journal |
Vaccines |
journalStr |
Vaccines |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2021 |
contenttype_str_mv |
txt |
author_browse |
Elisa Ramos-Sevillano Giuseppe Ercoli José Afonso Guerra-Assunção Philip Felgner Rafael Ramiro de Assis Rie Nakajima David Goldblatt Kevin Kweku Adjei Tetteh Robert Simon Heyderman Stephen Brian Gordon Daniela Mulari Ferreria Jeremy Stuart Brown |
container_volume |
9 |
format_se |
Elektronische Aufsätze |
author-letter |
Elisa Ramos-Sevillano |
doi_str_mv |
10.3390/vaccines9030261 |
author2-role |
verfasserin |
title_sort |
protective effect of nasal colonisation with <i<∆cps/piaa</i< and <i<∆cps/proabc</i<<i<streptococcus pneumoniae</i< strains against recolonisation and invasive infection |
title_auth |
Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection |
abstract |
Rationale: Nasopharyngeal administration of live virulence-attenuated <i<Streptococcus pneumoniae</i< strains is a potential novel preventative strategy. One target for creating reduced virulence <i<S. pneumoniae</i< strains is the capsule, but loss of the capsule reduces the duration of <i<S. pneumoniae</i< colonisation in mice which could impair protective efficacy against subsequent infection. Objectives: To assess protective efficacy of nasopharyngeal administration of unencapsulated <i<S. pneumoniae</i< strains in murine infection models. Methods: Strains containing <i<cps</i< locus deletions combined with the <i<S. pneumoniae</i< virulence factors <i<psaA</i< (reduces colonisation) or <i<proABC</i< (no effect on colonisation) were constructed and their virulence phenotypes and ability to prevent recolonisation or invasive infection assessed using mouse infection models. Serological responses to colonisation were compared between strains using ELISAs, immunoblots and 254 <i<S. pneumoniae</i< protein antigen array. Measurements and Main Results: The <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains were strongly attenuated in virulence in both invasive infection models and had a reduced ability to colonise the nasopharynx. ELISAs, immunoblots and protein arrays showed colonisation with either strain stimulated weaker serological responses than the wild type strain. Mice previously colonised with these strains were protected against septicaemic pneumonia but, unlike mice colonised with the wild type strain, not against <i<S. pneumoniae</i< recolonisation. Conclusions: Colonisation with the <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains prevented subsequent septicaemia, but in contrast, to published data for encapsulated double mutant strains they did not prevent recolonisation with <i<S. pneumoniae</i<. These data suggest targeting the <i<cps</i< locus is a less effective option for creating live attenuated strains that prevent <i<S. pneumoniae</i< infections. |
abstractGer |
Rationale: Nasopharyngeal administration of live virulence-attenuated <i<Streptococcus pneumoniae</i< strains is a potential novel preventative strategy. One target for creating reduced virulence <i<S. pneumoniae</i< strains is the capsule, but loss of the capsule reduces the duration of <i<S. pneumoniae</i< colonisation in mice which could impair protective efficacy against subsequent infection. Objectives: To assess protective efficacy of nasopharyngeal administration of unencapsulated <i<S. pneumoniae</i< strains in murine infection models. Methods: Strains containing <i<cps</i< locus deletions combined with the <i<S. pneumoniae</i< virulence factors <i<psaA</i< (reduces colonisation) or <i<proABC</i< (no effect on colonisation) were constructed and their virulence phenotypes and ability to prevent recolonisation or invasive infection assessed using mouse infection models. Serological responses to colonisation were compared between strains using ELISAs, immunoblots and 254 <i<S. pneumoniae</i< protein antigen array. Measurements and Main Results: The <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains were strongly attenuated in virulence in both invasive infection models and had a reduced ability to colonise the nasopharynx. ELISAs, immunoblots and protein arrays showed colonisation with either strain stimulated weaker serological responses than the wild type strain. Mice previously colonised with these strains were protected against septicaemic pneumonia but, unlike mice colonised with the wild type strain, not against <i<S. pneumoniae</i< recolonisation. Conclusions: Colonisation with the <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains prevented subsequent septicaemia, but in contrast, to published data for encapsulated double mutant strains they did not prevent recolonisation with <i<S. pneumoniae</i<. These data suggest targeting the <i<cps</i< locus is a less effective option for creating live attenuated strains that prevent <i<S. pneumoniae</i< infections. |
abstract_unstemmed |
Rationale: Nasopharyngeal administration of live virulence-attenuated <i<Streptococcus pneumoniae</i< strains is a potential novel preventative strategy. One target for creating reduced virulence <i<S. pneumoniae</i< strains is the capsule, but loss of the capsule reduces the duration of <i<S. pneumoniae</i< colonisation in mice which could impair protective efficacy against subsequent infection. Objectives: To assess protective efficacy of nasopharyngeal administration of unencapsulated <i<S. pneumoniae</i< strains in murine infection models. Methods: Strains containing <i<cps</i< locus deletions combined with the <i<S. pneumoniae</i< virulence factors <i<psaA</i< (reduces colonisation) or <i<proABC</i< (no effect on colonisation) were constructed and their virulence phenotypes and ability to prevent recolonisation or invasive infection assessed using mouse infection models. Serological responses to colonisation were compared between strains using ELISAs, immunoblots and 254 <i<S. pneumoniae</i< protein antigen array. Measurements and Main Results: The <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains were strongly attenuated in virulence in both invasive infection models and had a reduced ability to colonise the nasopharynx. ELISAs, immunoblots and protein arrays showed colonisation with either strain stimulated weaker serological responses than the wild type strain. Mice previously colonised with these strains were protected against septicaemic pneumonia but, unlike mice colonised with the wild type strain, not against <i<S. pneumoniae</i< recolonisation. Conclusions: Colonisation with the <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains prevented subsequent septicaemia, but in contrast, to published data for encapsulated double mutant strains they did not prevent recolonisation with <i<S. pneumoniae</i<. These data suggest targeting the <i<cps</i< locus is a less effective option for creating live attenuated strains that prevent <i<S. pneumoniae</i< infections. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
3, p 261 |
title_short |
Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection |
url |
https://doi.org/10.3390/vaccines9030261 https://doaj.org/article/49a7fad3616a46729a4e6aada6193bc7 https://www.mdpi.com/2076-393X/9/3/261 https://doaj.org/toc/2076-393X |
remote_bool |
true |
author2 |
Giuseppe Ercoli José Afonso Guerra-Assunção Philip Felgner Rafael Ramiro de Assis Rie Nakajima David Goldblatt Kevin Kweku Adjei Tetteh Robert Simon Heyderman Stephen Brian Gordon Daniela Mulari Ferreria Jeremy Stuart Brown |
author2Str |
Giuseppe Ercoli José Afonso Guerra-Assunção Philip Felgner Rafael Ramiro de Assis Rie Nakajima David Goldblatt Kevin Kweku Adjei Tetteh Robert Simon Heyderman Stephen Brian Gordon Daniela Mulari Ferreria Jeremy Stuart Brown |
ppnlink |
736559205 |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.3390/vaccines9030261 |
up_date |
2024-07-03T22:25:31.239Z |
_version_ |
1803598462968659969 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ079235166</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240412190923.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230307s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/vaccines9030261</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ079235166</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ49a7fad3616a46729a4e6aada6193bc7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Elisa Ramos-Sevillano</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Protective Effect of Nasal Colonisation with <i<∆cps/piaA</i< and <i<∆cps/proABC</i<<i<Streptococcus pneumoniae</i< Strains against Recolonisation and Invasive Infection</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Rationale: Nasopharyngeal administration of live virulence-attenuated <i<Streptococcus pneumoniae</i< strains is a potential novel preventative strategy. One target for creating reduced virulence <i<S. pneumoniae</i< strains is the capsule, but loss of the capsule reduces the duration of <i<S. pneumoniae</i< colonisation in mice which could impair protective efficacy against subsequent infection. Objectives: To assess protective efficacy of nasopharyngeal administration of unencapsulated <i<S. pneumoniae</i< strains in murine infection models. Methods: Strains containing <i<cps</i< locus deletions combined with the <i<S. pneumoniae</i< virulence factors <i<psaA</i< (reduces colonisation) or <i<proABC</i< (no effect on colonisation) were constructed and their virulence phenotypes and ability to prevent recolonisation or invasive infection assessed using mouse infection models. Serological responses to colonisation were compared between strains using ELISAs, immunoblots and 254 <i<S. pneumoniae</i< protein antigen array. Measurements and Main Results: The <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains were strongly attenuated in virulence in both invasive infection models and had a reduced ability to colonise the nasopharynx. ELISAs, immunoblots and protein arrays showed colonisation with either strain stimulated weaker serological responses than the wild type strain. Mice previously colonised with these strains were protected against septicaemic pneumonia but, unlike mice colonised with the wild type strain, not against <i<S. pneumoniae</i< recolonisation. Conclusions: Colonisation with the <i<∆cps/piaA</i< and <i<∆cps/proABC</i< strains prevented subsequent septicaemia, but in contrast, to published data for encapsulated double mutant strains they did not prevent recolonisation with <i<S. pneumoniae</i<. These data suggest targeting the <i<cps</i< locus is a less effective option for creating live attenuated strains that prevent <i<S. pneumoniae</i< infections.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<Streptococcus pneumoniae</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">capsule</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">vaccine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<psaA</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<proABC</i<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">colonisation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Giuseppe Ercoli</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">José Afonso Guerra-Assunção</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Philip Felgner</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rafael Ramiro de Assis</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Rie Nakajima</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">David Goldblatt</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kevin Kweku Adjei Tetteh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Robert Simon Heyderman</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Stephen Brian Gordon</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Daniela Mulari Ferreria</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jeremy Stuart Brown</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Vaccines</subfield><subfield code="d">MDPI AG, 2013</subfield><subfield code="g">9(2021), 3, p 261</subfield><subfield code="w">(DE-627)736559205</subfield><subfield code="w">(DE-600)2703319-3</subfield><subfield code="x">2076393X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:3, p 261</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/vaccines9030261</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/49a7fad3616a46729a4e6aada6193bc7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/2076-393X/9/3/261</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2076-393X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">2021</subfield><subfield code="e">3, p 261</subfield></datafield></record></collection>
|
score |
7.3996468 |